01 December 2007
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. ZondermanAnn Transplant 2008; 13(1): 36-36 :: ID: 880194
Abstract
Background: Our objective was to develop a high throughput, robust and simple method for quantification of any combination of immunosuppressants like sirolimus, tacrolimus, everolimus, and cyclosporin A by implementing APCI source and LC column multiplexing system.
Material/Methods: Blood samples were processed with a protein precipitation method and analyzed on 10-2.1 mm Hypersil C18 guard column with 2 min LC gradient method (1 min data collection time with two column switch method). Data was collected in MRM mode where ammoniated adducts of protonated molecules were used as precursor ions for all analytes. Ascomycin and cyclosporin D were used as internal standards. The whole blood calibrators and QC samples with concentrations across calibration range were prepared in house. The method was validated by processing and analyzing QC samples to obtain inter- and intra- assay variability. An interference study along with BioRad QC analysis was conducted to test method robustness. Extracted sample stability in autosampler rack at 8°C was obtained. Method was correlated with immunoassay by analyzing clinical samples.
Results: The quantification was performed with LOQ of 1 ng/mL and a linearity range 1-50 ng/mL for tacrolimus, sirolimus, everolimus and LOQ of 10 ng/mL and a linearity range of 10-2000 ng/mL for cyclosporin A. Intra and inter-assay CV's were all less than 10%. BioRad QC's results met supplier specification. No interferences were detected. Extracted samples were stable in 8°C for at least 24 hours.
Conclusions: Validation data demonstrates high throughput, robust method with a linearity range, accuracy and precision meeting industry standards.
Keywords: immunosuppressants, Everolimus, cyclosporin
206 0
In Press
14 Sep 2023 : Case report
Intrahepatic Venous Collateral Circulation and Reverse Blood Flow After Main Hepatic Vein Obstruction: A Ca...Ann Transplant In Press; DOI: 10.12659/AOT.941521
12 Sep 2023 : Original article
Three-Dimensional Printing of Polycaprolactone/Nano-Hydroxyapatite Composite Scaffolds with a Pore Size of ...Ann Transplant In Press; DOI: 10.12659/AOT.940365
04 Sep 2023 : Original article
Analysis of Anxiety and Influencing Factors in Kidney Transplant Recipients and General Public During the C...Ann Transplant In Press; DOI: 10.12659/AOT.941489
04 Sep 2023 : Original article
Prolonged Tracheal Intubation in the ICU as a Possible Risk Factor for Arytenoid Dislocation After Liver Tr...Ann Transplant In Press; DOI: 10.12659/AOT.940727
Most Viewed Current Articles
24 Aug 2021 : Review article
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860